Test Price
3,000 AED✅ Home Collection Available
Diabetes and Obesity Panel Genetic Test in Dubai | NGS Screening | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% diagnostic sensitivity via ISO 9001:2015 accredited Next‑Generation Sequencing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance
Post‑test telephonic consultation with a DHA‑licensed medical geneticist to review your results and recommended next steps.
Insurance Support
Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced genetic panel employs Next‑Generation Sequencing (NGS) to analyse over 100 genes associated with monogenic and polygenic forms of diabetes and obesity. The test identifies hereditary risk variants that may influence metabolic regulation, insulin secretion, and adipose tissue function, enabling clinicians to implement personalised prevention and early intervention strategies.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single‑Gene Testing) |
|---|---|---|
| Precision / Coverage | >100× depth, broad gene coverage, 99.9% sensitivity | Targets one gene at a time; lower sensitivity for rare variants |
| Methodology | Next‑Generation Sequencing (Illumina‑based) | Sanger sequencing or PCR‑based genotyping |
| Turnaround Time | 3–4 weeks | 6–8 weeks (if multiple genes tested sequentially) |
Physician Insight & Safety Protocols
“As a Consultant in Medical Genetics licensed by the DHA (registration 9294403), I emphasise that this comprehensive panel identifies hereditary susceptibility, not a predetermined diagnosis. When interpreted alongside your personal and family medical history, these insights empower your healthcare team to design targeted prevention and early intervention strategies that can meaningfully reduce your risk.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
Medication Safety Notice
Continue all prescribed treatments unless explicitly advised otherwise by your treating physician. This genetic assessment is designed to inform long‑term health planning and should not be used to modify current medication regimens without professional medical consultation.
Exclusion Criteria & Emergency Red Flags
- This test is intended for hereditary risk assessment and is not appropriate for acute diagnostic emergencies.
- If you experience sudden unintentional weight loss, excessive thirst, fruity breath odour, abdominal pain, or difficulty breathing, seek immediate emergency care.
- Does not replace routine glucose monitoring, HbA1c testing, or insulin therapy adjustments.
- For patients under 18 years of age, consent from a legal guardian is required in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the turnaround time for results?
Your results are typically available within 3 to 4 weeks after the laboratory receives your sample. This time frame allows for thorough sequencing, bioinformatics analysis, and clinical interpretation to ensure the highest possible accuracy.
2. Is a doctor’s referral required for this test in the UAE?
Yes, a referral from a DHA‑licensed physician is mandatory. We facilitate coordination with our network of endocrinologists and genetic specialists to ensure the test is clinically appropriate and that you receive proper pre‑ and post‑test counselling.
3. How is my genetic data protected under UAE law?
Your genetic information is protected under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All data is encrypted, access‑controlled, and never shared without your explicit consent.
4. Can lifestyle changes influence the risks identified by this panel?
Absolutely. This panel reveals genetic predispositions, but lifestyle factors such as diet, physical activity, and sleep hygiene play a critical role in modifying actual disease risk. Your clinician will use these results to create a personalised prevention plan that addresses both genetic and environmental contributors.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed, stored, and transmitted using enterprise‑grade encryption and strict access controls. Our laboratory holds ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139) and adheres to the highest standards of clinical data governance. Patient consent, data minimisation, and purpose limitation are core principles embedded in every workflow. For any data‑related inquiries, contact our Privacy Office at privacy@dnalabsuae.com.
Clinical & Logistical Metadata
| Test Name | Diabetes and Obesity Panel Genetic Test (NGS) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or saliva (Oragene‑DNA kit) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform |
| ICD‑10‑CM Code | Z13.1, E66.9 |
| LOINC Code | 94122-7 |
| DHA Facility License & Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians